Cargando…

Teriflunomide as a therapeutic means for myelin repair

BACKGROUND: Promotion of myelin repair in the context of demyelinating diseases such as multiple sclerosis (MS) still represents a clinical unmet need, given that this disease is not only characterized by autoimmune activities but also by impaired regeneration processes. Hence, this relates to repla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Göttle, Peter, Groh, Janos, Reiche, Laura, Gruchot, Joel, Rychlik, Nicole, Werner, Luisa, Samper Agrelo, Iria, Akkermann, Rainer, Zink, Annika, Prigione, Alessandro, Hartung, Hans-Peter, Martini, Rudolf, Küry, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826576/ https://www.ncbi.nlm.nih.gov/pubmed/36611185 http://dx.doi.org/10.1186/s12974-022-02686-6

Ejemplares similares

Teriflunomide promotes oligodendroglial differentiation and myelination
por: Göttle, Peter, et al.
Publicado: (2018)

TLR4 Associated Signaling Disrupters as a New Means to Overcome HERV-W Envelope-Mediated Myelination Deficits
por: Göttle, Peter, et al.
Publicado: (2021)

Identification of novel myelin repair drugs by modulation of oligodendroglial differentiation competence
por: Manousi, Anastasia, et al.
Publicado: (2021)

Myelin repair is fostered by the corticosteroid medrysone specifically acting on astroglial subpopulations
por: Silva Oliveira Junior, Markley, et al.
Publicado: (2022)

A Novel Ex Vivo Model to Study Therapeutic Treatments for Myelin Repair following Ischemic Damage
por: Werner, Luisa, et al.
Publicado: (2023)

Do Neural Stem Cells Have a Choice? Heterogenic Outcome of Cell Fate Acquisition in Different Injury Models
por: Beyer, Felix, et al.
Publicado: (2019)

Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis
por: Groh, Janos, et al.
Publicado: (2017)

Intracellular Protein Shuttling: A Mechanism Relevant for Myelin Repair in Multiple Sclerosis?
por: Göttle, Peter, et al.
Publicado: (2015)

Heterogeneous populations of neural stem cells contribute to myelin repair
por: Akkermann, Rainer, et al.
Publicado: (2017)

The Molecular Basis for Remyelination Failure in Multiple Sclerosis
por: Gruchot, Joel, et al.
Publicado: (2019)

Functional in vivo assessment of stem cell-secreted pro-oligodendroglial factors
por: Schira-Heinen, Jessica, et al.
Publicado: (2022)

Teriflunomide attenuates neuroinflammation-related neural damage in mice carrying human PLP1 mutations
por: Groh, Janos, et al.
Publicado: (2018)

Siponimod Modulates the Reaction of Microglial Cells to Pro-Inflammatory Stimulation
por: Gruchot, Joel, et al.
Publicado: (2022)

Aberrant Oligodendrogenesis in Down Syndrome: Shift in Gliogenesis?
por: Reiche, Laura, et al.
Publicado: (2019)

Secretome Analysis of Mesenchymal Stem Cell Factors Fostering Oligodendroglial Differentiation of Neural Stem Cells In Vivo
por: Samper Agrelo, Iria, et al.
Publicado: (2020)

Taking Advantage of Nature’s Gift: Can Endogenous Neural Stem Cells Improve Myelin Regeneration?
por: Akkermann, Rainer, et al.
Publicado: (2016)

Sildenafil Inhibits Myelin Expression and Myelination of Oligodendroglial Precursor Cells
por: Muñoz-Esquivel, Jonathan, et al.
Publicado: (2019)

Review of teriflunomide and its potential in the treatment of multiple sclerosis
por: Warnke, Clemens, et al.
Publicado: (2009)

An unmet clinical need: roads to remyelination in MS
por: Göttle, Peter, et al.
Publicado: (2019)

Drug repurposing for neuroregeneration in multiple sclerosis
por: Küry, Patrick, et al.
Publicado: (2018)

Multiple sclerosis drug repurposing for neuroregeneration
por: Göttle, Peter, et al.
Publicado: (2023)

CXCR7 Is Involved in Human Oligodendroglial Precursor Cell Maturation
por: Kremer, David, et al.
Publicado: (2016)

Neural Cell Responses Upon Exposure to Human Endogenous Retroviruses
por: Gruchot, Joel, et al.
Publicado: (2019)

Human endogenous retroviruses: ammunition for myeloid cells in neurodegenerative diseases?
por: Gruchot, Joel, et al.
Publicado: (2019)

Transgenic expression of the HERV-W envelope protein leads to polarized glial cell populations and a neurodegenerative environment
por: Gruchot, Joel, et al.
Publicado: (2023)

C21orf91 Regulates Oligodendroglial Precursor Cell Fate—A Switch in the Glial Lineage?
por: Reiche, Laura, et al.
Publicado: (2021)

Mesenchymal Stem Cell Conditioning Promotes Rat Oligodendroglial Cell Maturation
por: Jadasz, Janusz Joachim, et al.
Publicado: (2013)

An update of teriflunomide for treatment of multiple sclerosis
por: Oh, Jiwon, et al.
Publicado: (2013)

Teriflunomide: Lack of efficacy: case report
Publicado: (2022)

Lichenoid Drug Eruption Induced by Teriflunomide
por: Agharbi, Fatima-Zahra, et al.
Publicado: (2023)

Painful Small Fiber Neuropathy Associated With Teriflunomide: A Case Series and Literature Review Related to Teriflunomide and Leflunomide
por: Elrefaey, Ahmed, et al.
Publicado: (2023)

Transcriptional Profiling of Ligand Expression in Cell Specific Populations of the Adult Mouse Forebrain That Regulates Neurogenesis
por: Azim, Kasum, et al.
Publicado: (2018)

Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
por: Bar-Or, Amit, et al.
Publicado: (2014)

Role of oral teriflunomide in the management of multiple sclerosis
por: Tanasescu, Radu, et al.
Publicado: (2013)

Neuropathy in multiple sclerosis patients treated with teriflunomide
por: Kilic, Ahmet Kasim, et al.
Publicado: (2023)

The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies
por: Freedman, Mark S, et al.
Publicado: (2017)

Immune modulation attenuates infantile neuronal ceroid lipofuscinosis in mice before and after disease onset
por: Groh, Janos, et al.
Publicado: (2021)

Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
por: Chan, Andrew, et al.
Publicado: (2016)

Teriflunomide treatment reduces B cells in patients with MS
por: Gandoglia, Ilaria, et al.
Publicado: (2017)

Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity
por: Ambrosius, Björn, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ifjpm76ecvbd7ohqlclce2umdt